Substrates for peptidase S26.016: SpsB signal peptidase
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77 kDa membrane protein | Q5HEI2 | 1-684 | peptide-Ala30+Ala-peptide | P | Glu | Ala | Ser | Ala | Ala | Ala | Lys | Pro | Bruton et al., 2003 | |||
| Ac-Ala-Gly-Leu-Ile-Ala-Arg-Ala-Val-Thr-Ser-Gly-Ala-NH2 | Ac-Ala-Gly-Leu-Ile-Ala-Arg-Ala+Val-Thr-Ser-Gly-Ala-NH2 | S | Ile | Ala | Arg | Ala | Val | Thr | Ser | Gly | Sharkov & Cai, 2002 | |||||
| Ac-Ala-Gly-Pro-Arg-Pro-Thr-Arg-Ile-Ala-Phe-Gly-Ala-NH2 | Ac-Ala+Gly-Pro-Arg-Pro-Thr-Arg-Ile-Ala-Phe-Gly-Ala-NH2 | S | - | - | Ac | Ala | Gly | Pro | Arg | Pro | Sharkov & Cai, 2002 | |||||
| Ac-Ala-Gly-Pro-Thr-Ala-Arg-Ala-Val-Thr-Ser-Gly-Ala-NH2 | Ac-Ala-Gly-Pro-Thr-Ala-Arg-Ala+Val-Thr-Ser-Gly-Ala-NH2 | S | Thr | Ala | Arg | Ala | Val | Thr | Ser | Gly | Sharkov & Cai, 2002 | |||||
| Ac-Ala-Gly-Ser-Ala-Ser-Ala-Leu-Ala-Lys-Ile-Gly-Ala-NH2 | Ac-Ala-Gly-Ser-Ala-Ser-Ala-Leu-Ala+Lys-Ile-Gly-Ala-NH2 | S | Ser | Ala | Leu | Ala | Lys | Ile | Gly | Ala | Sharkov & Cai, 2002 | |||||
| Ac-Ala-Gly-Val-Pro-Pro-Leu-Phe-Ala-Met-Leu-Gly-Ala-NH2 | Ac-Ala-Gly-Val-Pro-Pro-Leu-Phe-Ala+Met-Leu-Gly-Ala-NH2 | S | Pro | Leu | Phe | Ala | Met | Leu | Gly | Ala | Sharkov & Cai, 2002 | |||||
| alpha-hemolysin | P09616 | 1-319 | peptide-Ala26+Ala-peptide | P | NT | Val | Ala | Gly | Ala | Ala | Asp | Ser | Asp | Gray & Kehoe, 1984 | ||
| beta-lactamase | P00807 | 1-281 | peptide-Ala24+Lys-peptide | P | NT | Ser | Ser | His | Ala | Lys | Glu | Leu | Asn | Ambler 1975 | ||
| chemotaxis inhibitory protein | A6QIG7 | 1-149 | peptide-Ala28+Phe-peptide | P | NT | Ser | Ala | Lys | Ala | Phe | Thr | Phe | Glu | de et al., 2004 | ||
| Decanoyl-Leu-Thr-Asn-Thr-Ala-Lys-Ala-Ala-Ser-Lys-Ile-Asp-Asp-OH | Decanoyl-Leu-Thr-Asn-Thr-Ala-Lys-Ala+Ala-Ser-Lys-Ile-Asp-Asp-OH | S | Thr | Ala | Lys | Ala | Ala | Ser | Lys | Ile | Bruton et al., 2003 | |||||
| Decanoyl-Leu-Thr-Asn-Thr-Ala-Lys-Ala-Glu-Ser-Lys-Ile-Asp-Asp-OH | Decanoyl-Leu-Thr-Asn-Thr-Ala-Lys-Ala+Glu-Ser-Lys-Ile-Asp-Asp-OH | S | Thr | Ala | Lys | Ala | Glu | Ser | Lys | Ile | Bruton et al., 2003 | |||||
| Decanoyl-Leu-Thr-Pro-Thr-Ala-Arg-Ala-Ala-Ser-Lys-Ile-Asp-Asp-OH | Decanoyl-Leu-Thr-Pro-Thr-Gln-Ala-Arg-Ala+Ala-Ser-Lys-Ile-Asp-Asp-OH | S | Thr | Ala | Arg | Ala | Ala | Ser | Lys | Ile | Bruton et al., 2003 | |||||
| Decanoyl-Leu-Thr-Pro-Thr-Ala-Asn-Ala-Ala-Ser-Lys-Ile-Asp-Asp-OH | Decanoyl-Leu-Thr-Pro-Thr-Gln-Ala-Asn-Ala+Ala-Ser-Lys-Ile-Asp-Asp-OH | S | Thr | Ala | Asn | Ala | Ala | Ser | Lys | Ile | Bruton et al., 2003 | |||||
| Decanoyl-Leu-Thr-Pro-Thr-Ala-Asp-Ala-Ala-Ser-Lys-Ile-Asp-Asp-OH | Decanoyl-Leu-Thr-Pro-Thr-Gln-Ala-Asp-Ala+Ala-Ser-Lys-Ile-Asp-Asp-OH | S | Thr | Ala | Lys | Ala | Ala | Ser | Lys | Ile | Bruton et al., 2003 | |||||
| Decanoyl-Leu-Thr-Pro-Thr-Ala-Leu-Ala-Ala-Ser-Lys-Ile-Asp-Asp-OH | Decanoyl-Leu-Thr-Pro-Thr-Gln-Ala-Leu-Ala+Ala-Ser-Lys-Ile-Asp-Asp-OH | S | Thr | Ala | Leu | Ala | Ala | Ser | Lys | Ile | Bruton et al., 2003 | |||||
| Decanoyl-Leu-Thr-Pro-Thr-Ala-Lys-Ala-Ala-Ser-Lys-Ile-Asp-Asp-OH | Decanoyl-Leu-Thr-Pro-Thr-Ala-Lys-Ala+Ala-Ser-Lys-Ile-Asp-Asp-OH | S | Thr | Ala | Lys | Ala | Ala | Ser | Lys | Ile | Bruton et al., 2003 | |||||
| Decanoyl-Leu-Thr-Pro-Thr-Ala-Lys-Ala-Ala-Ser-Lys-Ile-Asp-Asp-OH | Decanoyl-Leu-Thr-Pro-Thr-Ala-Lys-Ala+Ala-Ser-Lys-Ile-Asp-Asp-OH | S | Thr | Ala | Lys | Ala | Ala | Ser | Lys | Ile | Bruton et al., 2003 | |||||
| Decanoyl-Leu-Thr-Pro-Thr-Gln-Ala-Lys-Ala-Ala-Ser-Lys-Ile-Asp-Asp-OH | Decanoyl-Leu-Thr-Pro-Thr-Gln-Ala-Lys-Ala+Ala-Ser-Lys-Ile-Asp-Asp-OH | S | Gln | Ala | Lys | Ala | Ala | Ser | Lys | Ile | Bruton et al., 2003 | |||||
| enterotoxin type A | P0A0L2 | 1-257 | peptide-Gly24+Ser-peptide | P | NT | Leu | Val | Asn | Gly | Ser | Glu | Lys | Ser | Huang et al., 1987 | ||
| enterotoxin type B | P01552 | 1-266 | peptide-Ala27+Glu-peptide | P | NT | Asn | Val | Leu | Ala | Glu | Ser | Gln | Pro | Huang & Bergdoll, 1970 | ||
| enterotoxin type C-1 | P01553 | 1-266 | peptide-Ala27+Glu-peptide | P | NT | Asn | Val | Leu | Ala | Glu | Ser | Gln | Pro | Schmidt & Spero, 1983 | ||
| enterotoxin type C-2 | P34071 | 1-266 | peptide-Ala27+Glu-peptide | P | NT | Asn | Val | Leu | Ala | Glu | Ser | Gln | Pro | Bohach & Schlievert, 1989 | ||
| enterotoxin type D | P20723 | 1-258 | peptide-Ala25+Asn-peptide | P | NT | Asn | Val | Lys | Ala | Asn | Glu | Asn | Ile | Bruton et al., 2003 | ||
| enterotoxin type E | P12993 | 1-257 | peptide-Lys27+Ser-peptide | P | NT | Gly | Ser | Glu | Lys | Ser | Glu | Glu | Ile | Couch et al., 1988 | ||
| epidermal cell differentiation inhibitor | P24121 | 1-247 | peptide-Ala35+Ala-peptide | P | NT | Thr | Ser | Leu | Ala | Ala | Asp | Val | Lys | Sugai et al., 1990 | ||
| exfoliative toxin A | P09331 | 1-280 | peptide-Ala38+Glu-peptide | P | NT | His | Ala | Lys | Ala | Glu | Val | Ser | Ala | Bruton et al., 2003 | ||
| exfoliative toxin B | P09332 | 1-277 | peptide-Ala31+Lys-peptide | P | NT | Thr | Leu | Gln | Ala | Lys | Glu | Tyr | Ser | Bruton et al., 2003 | ||
| fibronectin-binding protein A | P14738 | 1-1018 | peptide-Ala36+Ala-peptide | P | NT | Lys | Glu | Ala | Ala | Ala | Ser | Glu | Gln | Bruton et al., 2003 | ||
| gamma-hemolysin component A | P0A074 | 1-309 | peptide-Ala29+Glu-peptide | P | NT | Ile | Ser | Lys | Ala | Glu | Asn | Lys | Ile | Kamio et al., 1993 | ||
| glycyl-glycine endopeptidase lytM | O33599 | 1-316 | peptide-Ala25+Ala-peptide | P | NT | Gln | Ala | Asp | Ala | Ala | Glu | Thr | Thr | Ramadurai & Jayaswal, 1997 | ||
| Hexanoyl-Leu-Thr-Pro-Thr-Gln-Ala-Lys-Ala-Ala-Ser-Lys-Ile-Asp-Asp-OH | Hexanoyl-Leu-Thr-Pro-Thr-Gln-Ala-Lys-Ala+Ala-Ser-Lys-Ile-Asp-Asp-OH | S | Gln | Ala | Lys | Ala | Ala | Ser | Lys | Ile | Bruton et al., 2003 | |||||
| immunodominant staphylococcal antigen B | Q9LAB5 | 1-175 | peptide-Ala36+Ala-peptide | P | NT | Gln | Ala | Gln | Ala | Ala | Ile | Thr | Pro | Lorenz et al., 2000 | ||
| leukocidin-F subunit | P31715 | 1-323 | peptide-Asn25+Ala-peptide | P | NT | Gly | Thr | Ala | Asn | Ala | Glu | Gly | Lys | Rahman et al., 1992 | ||
| leukocidin-S subunit | P31716 | 1-315 | peptide-Ala29+Ala-peptide | P | NT | Asn | Ala | Lys | Ala | Ala | Asn | Asp | Thr | Rahman et al., 1991 | ||
| phospholipase C | P09978 | 1-330 | peptide-Ala34+Glu-peptide | P | NT | Ser | Ala | Lys | Ala | Glu | Ser | Lys | Lys | Bruton et al., 2003 | ||
| probable transglycosylase isaA | Q2FV52 | 1-233 | peptide-Ala29+Ala-peptide | P | NT | Gln | Ala | His | Ala | Ala | Glu | Val | Asn | Ziebandt et al., 2001 | ||
| probable transglycosylase isaA | P60158 | 1-233 | peptide-Ala29+Ala-peptide | P | NT | Gln | Ala | His | Ala | Ala | Glu | Val | Asn | Lorenz et al., 2000 | ||
| probable transglycosylase isaA | Q5HCY1 | 1-233 | peptide-Ala29+Ala-peptide | P | NT | Gln | Ala | His | Ala | Ala | Glu | Val | Asn | Ziebandt et al., 2001 | ||
| probable transglycosylase sceD | Q5HEA4 | 1-231 | peptide-Ala27+Ser-peptide | P | NT | Glu | Ala | His | Ala | Ser | Glu | Ala | Asp | Ziebandt et al., 2001 | ||
| protein A | Q53759 | 1-454 | peptide-Ala48+Ala-peptide | P | NT | Ala | Ala | Asn | Ala | Ala | Gln | His | Asp | Bruton et al., 2003 | ||
| protein map | Q53599 | 1-689 | peptide-Ala30+Ala-peptide | P | NT | Glu | Ala | Ser | Ala | Ala | Ala | Lys | Gln | Joensson et al., 1995 | ||
| serine protease splA | Q2FXC2 | 1-235 | peptide-Ala35+Glu-peptide | P | NT | Ile | Ala | Lys | Ala | Glu | Lys | Asn | Val | Reed et al., 2001 | ||
| serine protease splB | Q2FXC3 | 1-240 | peptide-Ala36+Glu-peptide | P | NT | Thr | Ala | Lys | Ala | Glu | Asn | Asn | Val | Reed et al., 2001 | ||
| serine protease splC | Q2FXC4 | 1-239 | peptide-Ala36+Glu-peptide | P | NT | Ile | Ala | Asn | Ala | Glu | Lys | Asn | Val | Reed et al., 2001 | ||
| serine protease splF | Q2FXC8 | 1-239 | peptide-Ala36+Glu-peptide | P | NT | Thr | Ala | Lys | Ala | Glu | Asn | Thr | Val | Reed et al., 2001 | ||
| staphopain B | Q2FZL3 | 1-393 | peptide-Ala36+Asp-peptide | P | NT | Lys | Ala | Lys | Ala | Asp | Ser | His | Ser | Rice et al., 2001 | ||
| staphylocoagulase | P07767 | 1-658 | peptide-Ala26+Ile-peptide | P | NT | Lys | Ala | Asp | Ala | Ile | Val | Thr | Lys | Kawabata et al., 1986 | ||
| staphylokinase | P68802 | 1-163 | peptide-Ala27+Ser-peptide | P | NT | Glu | Val | Ser | Ala | Ser | Ser | Ser | Phe | Bruton et al., 2003 | ||
| toxic shock syndrome toxin-1 | P06886 | 1-234 | peptide-Ala40+Ser-peptide | P | NT | Thr | Ala | Lys | Ala | Ser | Thr | Asn | Asp | Bruton et al., 2003 |
